Show
Sort by
-
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
-
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials
-
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144 -
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply
-
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review
-
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab
-
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management